World's Best Scientists 2026 revealed!
Award Badge
Microbiology
Korea
2026

D-Index & Metrics

Microbiology

D-Index
73
Citations
32381
World Ranking
1616
National Ranking
5

Research.com Recognitions

  • 2026 - Research.com Microbiology in Korea Leader Award
  • 2025 - Research.com Microbiology in Korea Leader Award

Overview

Myoung-don Oh is affiliated with Seoul National University in South Korea. Their research primarily focuses on medicine, with an emphasis on infectious diseases, epidemiology, oncology, neurology, and molecular medicine.

The scientist's notable recent publications include:

  • "Remdesivir for the Treatment of Covid-19 - Final Report" (2020), published in the New England Journal of Medicine
  • "Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19" (2020), published in the New England Journal of Medicine
  • "A minimal common outcome measure set for COVID-19 clinical research" (2020), published in The Lancet Infectious Diseases
  • "COVID-19: towards controlling of a pandemic" (2020), published in The Lancet
  • "The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: Implication for Infection Prevention and Control Measures" (2020), published in the Journal of Korean Medical Science

The main topics covered in their research include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Antibiotic Resistance in Bacteria
  • Bacterial Identification and Susceptibility Testing
  • COVID-19 and healthcare impacts
  • Neutropenia and Cancer Infections

Frequent co-authors collaborating with Myoung-don Oh are:

  • Nam Joong Kim
  • Chang Kyung Kang
  • Wan Beom Park
  • Pyoeng Gyun Choe
  • Eu Suk Kim

The scientist has published extensively in several journals, including:

  • Journal of Korean Medical Science
  • Open Forum Infectious Diseases
  • Emerging Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Korean Journal of Internal Medicine

The scope of Myoung-don Oh's work is marked by a strong focus on infectious diseases, particularly relating to the COVID-19 pandemic, as well as broader topics in epidemiology and bacterial resistance. Their publication record demonstrates active engagement in both clinical and molecular research domains.

Best Publications

  • Remdesivir for the Treatment of Covid-19 - Final Report.

    John H. Beigel;Kay M. Tomashek;Lori E. Dodd;Aneesh K. Mehta

  • Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.

    Andre C Kalil;Thomas F Patterson;Aneesh K Mehta;Kay M Tomashek

  • A minimal common outcome measure set for COVID-19 clinical research

    John C. Marshall;Srinivas Murthy;Janet Diaz;Neil Adhikari

  • COVID-19: towards controlling of a pandemic.

    Juliet Bedford;Delia Enria;Johan Giesecke;David L Heymann

  • Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome

    Cheol-In Kang;Sung-Han Kim;Wan Beom Park;Ki-Deok Lee

  • Severe fever with thrombocytopenia syndrome, South Korea, 2012.

    Kye-Hyung Kim;Jongyoun Yi;Gayeon Kim;Su Jin Choi

  • Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Influence of Delayed Receipt of Effective Antimicrobial Therapy on Clinical Outcome

    Cheol-In Kang;Sung-Han Kim;Hong-Bin Kim;Sang-Won Park

  • Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission

    David S. Hui;Esam I. Azhar;Yae Jean Kim;Ziad A. Memish;Ziad A. Memish

  • The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial

    Wan Beom Park;Nak Hyun Kim;Kye Hyung Kim;Seung Hwan Lee

  • The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: Implication for Infection Prevention and Control Measures.

    Jin Yong Kim;Pyoeng Gyun Choe;Yoonju Oh;Kyung Joong Oh

  • Bloodstream Infections Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Mortality and Treatment Outcome, with Special Emphasis on Antimicrobial Therapy

    Cheol-In Kang;Sung-Han Kim;Wan Beom Park;Ki-Deok Lee

  • Outcome of Vancomycin Treatment in Patients with Methicillin-Susceptible Staphylococcus aureus Bacteremia

    Sung Han Kim;Kye Hyung Kim;Hong Bin Kim;Nam Joong Kim

  • Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19

    Eu Suk Kim;Bum Sik Chin;Chang Kyung Kang;Nam Joong Kim

  • Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial.

    Kayvon Modjarrad;Christine C. Roberts;Kristin T. Mills;Amy R. Castellano

  • Epidemiology and Clinical Features of Bloodstream Infections Caused by AmpC-Type-β-Lactamase-Producing Klebsiella pneumoniae

    Hyunjoo Pai;Cheol In Kang;Jeong Hum Byeon;Ki Deok Lee

  • Virus Isolation from the First Patient with SARS-CoV-2 in Korea.

    Wan Beom Park;Wan Beom Park;Nak Jung Kwon;Su Jin Choi;Chang Kyung Kang

  • A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein.

    Cheolmin Kim;Dong Kyun Ryu;Jihun Lee;Young Il Kim

  • MERS-CoV Antibody Responses 1 Year After Symptom Onset, South Korea, 2015

    Pyoeng Gyun Choe;R. A.P.M. Perera;Wan Beom Park;Kyoung Ho Song

  • Viral Load Kinetics of MERS Coronavirus Infection.

    Myoung Don Oh;Wan Beom Park;Pyoeng Gyun Choe;Su Jin Choi

  • Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea.

    Myoung Don Oh;Wan Beom Park;Sang Won Park;Pyoeng Gyun Choe

  • Diagnostic Usefulness of a T-cell–Based Assay for Extrapulmonary Tuberculosis

    Sung-Han Kim;Su-Jin Choi;Hong-Bin Kim;Nam-Joong Kim

  • Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection.

    Eu Suk Kim;Pyoeng Gyun Choe;Wan Beom Park;Hong Sang Oh

Frequent Co-Authors

Eui Chong Kim
Eui Chong Kim Seoul National University
Cheol-In Kang
Cheol-In Kang Sungkyunkwan University
Ki-Hyun Kim
Ki-Hyun Kim Hanyang University
Ziad A. Memish
Ziad A. Memish Emory University
Seock-Ah Im
Seock-Ah Im Seoul National University Hospital
Dong-Wan Kim
Dong-Wan Kim Seoul National University Hospital
Ranawaka A.P.M. Perera
Ranawaka A.P.M. Perera University of Hong Kong
Malik Peiris
Malik Peiris University of Hong Kong
Leo L. M. Poon
Leo L. M. Poon University of Hong Kong
Young Ki Choi
Young Ki Choi Institute for Basic Science

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students studying Microbiology in the USA, exploring related online degrees can open diverse career opportunities beyond traditional laboratory roles. Fields like healthcare and information management increasingly require specialized skills that complement microbiology knowledge.

One important consideration is accessibility—many are curious about the best degree for felons, highlighting programs that offer second chances and flexible pathways for those with past convictions. Microbiology-related fields can align well with such accessible degree options, especially in allied health or administrative roles.

Another growing area is in integrative health, such as becoming a functional medicine NP. This role combines clinical expertise with a holistic approach, which pairs well with microbiological insights into infection and immune system functions.

For those interested in healthcare data, earning a professional coder certification or pursuing a bachelor of science in health information management salary-oriented degree can expand career prospects in health information systems, medical billing, and coding. These fields rely on precise microbial and clinical data knowledge, making them ideal complementary pathways for microbiology graduates.

Best Scientists Citing Myoung-don Oh

Trending Scientists